COMPANY PROFILE

HiberCell

Explore full profile

Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis

Roseville, United StatesFounded 2019Biotech & Life Sciences

Valuation $250–500M Last recorded · 2021

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About HiberCell

HiberCell is a biotechnology company dedicated to developing therapeutic molecules that address the biology and mechanisms of tumor dormancy. The company focuses on overcoming foundational barriers that prevent patients from living longer, cancer-free lives. HiberCell operates in the oncology market, serving patients and healthcare providers by offering innovative treatments aimed at modulating tumor dormancy. The business model revolves around research and development of novel therapies, securing funding through venture capital and debt facilities, and forming strategic collaborations for diagnostic discovery and commercialization. Revenue is generated through the development and eventual commercialization of these therapeutic solutions. HiberCell's recent financial activities include closing a $67.4 million Series B financing and securing a $30 million debt facility from Hercules Capital. The company also collaborates with Biodesix for companion diagnostic discovery and development.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: Roseville, United States
Employees: 26
Open positions: None listed
Dealroom signal: 71.6/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus: b2b
Investment activity: 1 company, latest Aug 2021
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBTDebt	May 2021	$30M	—	Hercules Capital	—
SERIES BOther financing	May 2021	$67M	$270M	Bristol-Myers Squibb · Hercules Capital · 6 Dimensions Capital · Trinitas Capital	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

HiberCell website traffic

Latest recorded traffic for HiberCell is 2.3K monthly website visits, up 35.3% over the last three months. HiberCell's team declined 3.7% over the past year.

Latest monthly visits2.3K 3-month web change+35.3% 1-year team growth-3.7%

Monthly website visitsMay 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RBRidge BiotechnologiesAI-enabled platform for precision enzyme and drug design	Palo Alto, United States	Operational	15	$25M	$100M
DPDISCO PharmaceuticalsBiotechnological research as well as the development, production and distribution of biotechnological products and solutions of all kinds	Cologne, Germany	Operational
ALAlphaTauAlpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors	Jerusalem, Israel	Operational
NANanoligentThe research and development to clinical phases of innovative cancer treatments based on protein nanoparticles	Cerdanyola del Vallès, Spain	Operational
CECellSpringThe Next Level in 3D Cell Culture	Zurich, Switzerland	Operational
MTMetabolomic TechnologiesCommitted to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs	Edmonton, Canada	Operational
TSTheranosis Life SciencesA fully functioning cell culture facility and molecular biology setup	Hyderabad, India	Operational
BTBeijing Immunochina Medical Science and TechnologyBeijing Immunochina Medical Science and Technology is a Chinese medical technology company	Haidian, China	Operational